Hepatoma research

Keyphrases

Publications

volume 6, 2020

Nahum Méndez-Sánchez, Alejandro Valencia-Rodriguez, Alfonso Vera-Barajas, Ludovico Abenavoli, Emidio Scarpellini, Guadalupe Ponciano-Rodriguez, David Q-H Wang
The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer. Hepatoma research 6 (2020)
Cem Simsek, Amy Kim, Michelle Ma, Nilay Danis, Merve Gurakar, Andrew M Cameron, Benjamin Philosophe, Jacqueline Garonzik-Wang, Shane Ottmann, Ahmet Gurakar, Behnam Saberi
Recurrence of hepatocellular carcinoma following deceased donor liver transplantation: case series. Hepatoma research 6 (2020)
Azeez Osho, Nicole E Rich, Amit G Singal
Role of imaging in management of hepatocellular carcinoma: surveillance, diagnosis, and treatment response. Hepatoma research 6 (2020)
Jihane N Benhammou, Jonathan Lin, Shehnaz K Hussain, Mohamed El-Kabany
Emerging risk factors for nonalcoholic fatty liver disease associated hepatocellular carcinoma. Hepatoma research 6 (2020)
Cecilia Monge Bonilla, Nicole A McGrath, Jianyang Fu, Changqing Xie
Immunotherapy of hepatocellular carcinoma with infection of hepatitis B or C virus. Hepatoma research 6 (2020)
Grant Yoneoka, Kliment Bozhilov, Linda L Wong
Prognostic ability of inflammation-based markers in radioembolization for hepatocellular carcinoma. Hepatoma research 6 (2020)
Ryan L Brunsing, Kathryn J Fowler, Takeshi Yokoo, Guilherme Moura Cunha, Claude B Sirlin, Robert M Marks
Alternative approach of hepatocellular carcinoma surveillance: abbreviated MRI. Hepatoma research 6 (2020)
Claudia P Oliveira, Angelo Paredes, Mohammed Siddiqui, Lawrence Serfaty, Abhijit Chowdhury, Jose Tadeu Stefano, Denise Siqueira Vanni, Sherry Boyett, Arun J Sanyal
The transcontinental variability of nonalcoholic fatty liver disease. Hepatoma research 6 (2020)

volume 5, 2019

Tomoki Sempokuya, Linda L Wong
Ten-year survival and recurrence of hepatocellular cancer. Hepatoma research 5 (2019)
Stephanie M Rutledge, Hui Zheng, Darrick K Li, Raymond T Chung
No evidence for higher rates of hepatocellular carcinoma after direct-acting antiviral treatment: a meta-analysis. Hepatoma research 5 (2019)
Bubu A Banini, Arun J Sanyal
The use of cell free DNA in the diagnosis of HCC. Hepatoma research 5 (2019)
Brian I Carr
Review of therapies for intermediate and advanced stage hepatocellular carcinoma, not suitable for curative therapies: a rapidly changing landscape. Hepatoma research 5 (2019)

volume 4, 2018

Eric M Wu, Linda L Wong, Brenda Y Hernandez, Jun-Fang Ji, Wei Jia, Sandi A Kwee, Sumodh Kalathil
Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/steatohepatitis and liver transplantation. Hepatoma research 4 (2018)
Ying Fu, Fung-Lung Chung
Oxidative stress and hepatocarcinogenesis. Hepatoma research 4 (2018)
Taoyang Chen, Gengsun Qian, Chunsun Fan, Yan Sun, Jinbing Wang, Peixin Lu, Xuefeng Xue, Yan Wu, Qinan Zhang, Yan Jin, Yiqian Wu, Yu Gan, Jianquan Lu, Thomas W Kensler, John D Groopman, Hong Tu
Qidong hepatitis B virus infection cohort: a 25-year prospective study in high risk area of primary liver cancer. Hepatoma research 4 (2018)
Saranya Chidambaranathan-Reghupaty, Rachel Mendoza, Paul B Fisher, Devanand Sarkar
The multifaceted oncogene SND1 in cancer: focus on hepatocellular carcinoma. Hepatoma research 4 (2018)
Scott T Nishioka, Miles M Sato, Linda L Wong, Maarit Tiirikainen, Sandi A Kwee
Clinical and molecular sub-classification of hepatocellular carcinoma relative to alpha-fetoprotein level in an Asia-Pacific island cohort. Hepatoma research 4 (2018)

volume 3, 2017

Nancy Magee, Yuxia Zhang
Role of early growth response 1 in liver metabolism and liver cancer. Hepatoma research 3 (2017)
Hie-Won Hann, Surbhi Jain, Grace Park, Jamin D Steffen, Wei Song, Ying-Hsiu Su
Detection of urine DNA markers for monitoring recurrent hepatocellular carcinoma. Hepatoma research 3 (2017)
Joy Sarkar, Thomas DeLeon, Linda L Wong
MELD score and AST-to-platelet ratio index (APRI) predict long-term survival in patients with a small hepatocellular carcinoma following non-transplant therapies: a pilot study. Hepatoma research 3 (2017)
Julia A Zhang, Sandi A Kwee, Linda L Wong
Late recurrence of hepatocellular carcinoma after liver transplantation. Hepatoma research 3 (2017)
Tim Link, Tomoo Iwakuma
Roles of p53 in extrinsic factor-induced liver carcinogenesis. Hepatoma research 3 (2017)

volume 2, 2016

R Jason Lamontagne, Sumedha Bagga, Michael J Bouchard
Hepatitis B virus molecular biology and pathogenesis. Hepatoma research 2 (2016)
Atul Ranjan, Kaustav Bera, Tomoo Iwakuma
Murine double minute 2, a potential p53-independent regulator of liver cancer metastasis. Hepatoma research 2 (2016)
Jing Shen, Qiao Wang, Irina Gurvich, Helen Remotti, Regina M Santella
Evaluating normalization approaches for the better identification of aberrant microRNAs associated with hepatocellular carcinoma. Hepatoma research 2 (2016)
Jing Shen, Abby B Siegel, Helen Remotti, Qiao Wang, Regina M Santella
Identifying microRNA panels specifically associated with hepatocellular carcinoma and its different etiologies. Hepatoma research 2 (2016)

Hepatoma research

Keyphrases

Publications

volume 9, 2023

volume 8, 2022

volume 7, 2021

volume 6, 2020

volume 5, 2019

volume 4, 2018

volume 3, 2017

volume 2, 2016